EXW3:XETRA:XETRA-iShares STOXX Europe 50 UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 45.45

Change

-0.15 (-0.32)%

Market Cap

USD 0.12B

Volume

1.10K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.91 (-1.97%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.61 (+0.61%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.51 (-2.11%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.12 (-0.89%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.06 (-1.16%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.20 (-0.85%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.12 (+0.93%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.11 (-0.19%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.12 (+1.20%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.07 (+0.06%)

USD 12.26B

ETFs Containing EXW3:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.88% 82% B 76% C+
Dividend Return -26.40% 20% F 8% B-
Total Return -19.52% 6% D- 7% C-
Trailing 12 Months  
Capital Gain -0.09% 25% F 31% F
Dividend Return -22.55% 23% F 5% F
Total Return -22.64% 5% F 9% A-
Trailing 5 Years  
Capital Gain 65.33% 56% F 58% F
Dividend Return -25.62% 17% F 3% F
Total Return 39.71% 44% F 46% F
Average Annual (5 Year Horizon)  
Capital Gain 10.13% 67% D+ 67% D+
Dividend Return 10.73% 68% D+ 67% D+
Total Return 0.60% 57% F 37% F
Risk Return Profile  
Volatility (Standard Deviation) 10.06% 62% D 70% C-
Risk Adjusted Return 106.61% 92% A 93% A
Market Capitalization 0.12B 40% F 31% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.